Glaucoma is a progressive optic neuropathy and a leading cause of irreversible blindness.
The disease has conventionally been characterized by an elevated intraocular pressure …

Matrix metalloproteinases (MMPs) are a family of proteolytic enzymes that degrade
extracellular matrix (ECM) components such as collagen and have important roles in …

Purpose To evaluate the intraocular pressure (IOP)-lowering performance and safety of an
ab interno gelatin stent (XEN 45 Gel Stent, Allergan plc, Irvine, California, USA), a minimally …

Purpose To compare the efficacy of different microinvasive glaucoma surgery (MIGS)
devices for reducing intraocular pressure (IOP) and medications in open-angle glaucoma …

Purpose To evaluate the frequency of 11 commonly cited barriers to optimal glaucoma
medication adherence among glaucoma patients and to identify barriers contributing to poor …

Purpose To evaluate the intraocular pressure (IOP)-lowering efficacy and safety of 10-and
15-μg bimatoprost implant in subjects with open-angle glaucoma (OAG) and ocular …

Purpose To report 3-year outcomes of the HORIZON study comparing cataract surgery (CS)
with Hydrus Microstent (Ivantis, Inc) implantation versus CS alone. Design Multicenter …

purpose. To formulate and characterize a drug-eluting contact lens designed to provide
extended, controlled release of a drug. methods. Prototype contact lenses were created by …

Objective The objective of this study was to evaluate the safety and intraocular pressure
(IOP)-lowering effects over 24 months of biodegradable bimatoprost sustained-release …

For nearly half a century, contact lenses have been proposed as a means of ocular drug
delivery, but achieving controlled drug release has been a significant challenge. We have …